GlassScriptPhysician profile
Starane Shepherd
NPI 1922391523
$268.01
in general payments reported to CMS, 2019-2025
8 companies · $40.00 in 2025
The $40.00 reported for 2025 was less than what a typical Neurocritical Care provider received nationally (typical 2025 total: $95.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.31 · 2022: $40.35 · 2023: $88.87 · 2024: $67.48 · 2025: $40.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immedica Pharma US, INC. | $88.87 | 2023 | |
| Medtronic, INC. | $40.35 | 2022 | |
| Janssen Biotech, INC. | $40.00 | 2025 | |
| Edwards Lifesciences Corporation | $34.68 | 2024 | Hemosphere |
| Zoll Circulation INC | $31.31 | 2019 | |
| Stryker Corporation | $17.01 | 2024 | Mild Device Kit |
| Haemonetics Corporation | $15.79 | 2024 | Teg6s Hemostasis System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Starane Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.